GUARDANT HEALTH, INC. Cost of Revenue
GUARDANT HEALTH, INC. (GH) reported Cost of Revenue of $115.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-30
- GUARDANT HEALTH, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $115.95M, a 42.79% increase year-over-year.
- GUARDANT HEALTH, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $104.92M, a 40.41% increase year-over-year.
- GUARDANT HEALTH, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $99.49M, a 28.22% increase year-over-year.
- GUARDANT HEALTH, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $93.59M, a 25.64% increase year-over-year.
- GUARDANT HEALTH, INC. cost of goods and services sold for fiscal 2025 was $349.01M, a 20.43% increase from fiscal 2024.
- GUARDANT HEALTH, INC. cost of goods and services sold for fiscal 2024 was $289.80M, a 27.64% increase from fiscal 2023.
- GUARDANT HEALTH, INC. cost of goods and services sold for fiscal 2023 was $227.05M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $115.95M 10-Q · filed 2026-07-30 | $220.87M 10-Q · filed 2026-07-30 | $320.36M derived: sum of 3 quarters · filed 2026-07-30 | $413.95M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $104.92M 10-Q · filed 2026-05-07 | $204.41M derived: sum of 2 quarters · filed 2026-05-07 | $298.00M derived: sum of 3 quarters · filed 2026-05-07 | $379.20M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $99.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $193.08M derived: sum of 2 quarters · filed 2026-02-19 | $274.28M derived: sum of 3 quarters · filed 2026-07-30 | $349.01M 10-K · filed 2026-02-19 |
| 2025-09-30 | $93.59M 10-Q · filed 2025-10-29 | $174.79M derived: sum of 2 quarters · filed 2026-07-30 | $249.51M 10-Q · filed 2025-10-29 | $327.11M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $81.20M 10-Q · filed 2026-07-30 | $155.93M 10-Q · filed 2026-07-30 | $233.52M derived: sum of 3 quarters · filed 2026-07-30 | $308.01M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $74.72M 10-Q · filed 2026-05-07 | $152.32M derived: sum of 2 quarters · filed 2026-05-07 | $226.81M derived: sum of 3 quarters · filed 2026-05-07 | $299.23M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $77.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $152.08M derived: sum of 2 quarters · filed 2026-02-19 | $224.50M derived: sum of 3 quarters · filed 2026-02-19 | $289.80M 10-K · filed 2026-02-19 |
| 2024-09-30 | $74.49M 10-Q · filed 2025-10-29 | $146.91M derived: sum of 2 quarters · filed 2025-10-29 | $212.21M 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $72.42M 10-Q · filed 2025-07-30 | $137.72M 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $65.30M 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | $227.05M 10-K · filed 2026-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |